Compare Boston Scientific Corporation (BSX) vs IAC/Interactivecorp (PPLI) Price & Performance

Boston Scientific (BSX) trades at $51.66, up 2.38% today, showing strong momentum with three consecutive quarterly earnings beats. The stock maintains bullish technical signals with moving averages supporting upward movement, though oscillators indicate potential overbought conditions. Fundamentally, BSX demonstrates robust growth with 2025 revenue reaching $20.07B and net income margin expanding to 14.43%, supported by strong cash flow generation of $1.54B in 2025.

The outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target offering 30% upside potential. Key risks include competitive pressures in WATCHMAN and electrophysiology segments, along with recent guidance cuts. Insider buying by the CEO and director signals management confidence in the company's long-term prospects despite near-term challenges.

PPLI trades at $40.60, down 0.15% on the day, with a bearish technical signal. Recent Q2 2026 earnings beat expectations at $6.77 EPS, driven by digital growth and MGM investment gains. The company shows strong profitability margins but volatile cash flows, with a net cash outflow of $820.42 million in 2025. Valuation ratios appear attractive with a P/E of 6.76 and P/B of 0.59.

Outlook is mixed: analyst consensus is bullish with a $60.50 price target, but risks include inconsistent earnings, high debt, and negative operating cash flow. The stock offers value potential if turnaround plans succeed, yet faces execution challenges in monetizing non-core assets.